These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 6586112

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [A randomized controlled study on vindesine and vincristine in combination with prednisolone in the treatment of adult acute lymphocytic leukemia and blastic crisis of chronic myeloid leukemia].
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2500-8. PubMed ID: 6580840
    [Abstract] [Full Text] [Related]

  • 5. Treatment of the blastic crisis of chronic myelogenous leukemia with the combination of vindesine and prednisolone, and cytosine arabinoside.
    Uzuka Y, Saito Y.
    Tohoku J Exp Med; 1983 Apr; 139(4):419-20. PubMed ID: 6575487
    [Abstract] [Full Text] [Related]

  • 6. [Blast crisis in chronic myeloid leukemia. Results with vindesine and prednisolone].
    Nitsche D, Tschurtschenthaler G, Stöger M, Michlmayr G.
    Dtsch Med Wochenschr; 1985 Dec 13; 110(50):1936-9. PubMed ID: 3865760
    [Abstract] [Full Text] [Related]

  • 7. Vindesine-prednisone in the treatment of blast crisis of chronic myeloid leukemia.
    Lemoine F, Najman A, Laporte JP, Gorin NC, Duhamel G.
    Cancer Treat Rep; 1985 Feb 13; 69(2):203-4. PubMed ID: 3855698
    [Abstract] [Full Text] [Related]

  • 8. Combination of vindesine and prednisone in malignant lymphoma and acute leukemia.
    Raich PC, Walker BK, Rogers JS, Subramanian VP, Fontana JA, Knost JA, Denning B.
    Cancer Treat Rep; 1983 May 13; 67(5):485-7. PubMed ID: 6573959
    [Abstract] [Full Text] [Related]

  • 9. [Induction of Ph-negative normal clone and long-term survival by combined treatment with G-CSF plus middle dose cytosine arabinoside for patients with chronic myeloid leukemia in blastic transformation].
    Katagiri T, Miyazawa K, Uchida Y, Hayashi S, Iwama H, Shyohji N, Kawakubo K, Shimamoto T, Inatomi Y, Kuriyama Y, Yaguchi M, Nehashi Y, Ohyashiki K, Toyama K.
    Rinsho Ketsueki; 1998 Dec 13; 39(12):1149-56. PubMed ID: 10028846
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Two cases of acute myelogenous leukemia with eosinophilia which progressed into complete remission with the treatment mainly consisting of vindesine and prednisolone].
    Yamada O, Naohara T, Aoyama M, Totsuka K, Muto K, Ito N, Otani T, Oshimi K, Mizoguchi H, Okada M.
    Rinsho Ketsueki; 1983 Jan 13; 24(1):45-50. PubMed ID: 6573521
    [No Abstract] [Full Text] [Related]

  • 12. [Chemotherapy of chronic myelogenous leukemia--VP(M) regimen initiated during its chronic phase, and evaluation of MCNU in the phase of blastic crisis].
    Kitajima K, Adachi T, Takahashi I, Nakada H, Osada K, Fukuda S, Ohmoto E, Aoyama S, Yorimitsu S, Sanada H.
    Gan To Kagaku Ryoho; 1989 Nov 13; 16(11):3573-9. PubMed ID: 2817908
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Idarubicin/cytosine arabinoside and mitoxantrone/etoposide for the treatment of de novo acute myelogenous leukemia.
    Haas R, Ho AD, Del Valle F, Fischer JT, Ehrhardt R, Döhner H, Witt B, Huberts H, Kaplan E, Hunstein W.
    Semin Oncol; 1993 Dec 13; 20(6 Suppl 8):20-6. PubMed ID: 8290968
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Therapy of the blast crisis in chronic myeloid leukemia. Results of a phase II study with vindesine].
    Hellriegel KP.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981 Dec 13; 108(5):699-706. PubMed ID: 6172337
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis.
    Derderian PM, Kantarjian HM, Talpaz M, O'Brien S, Cork A, Estey E, Pierce S, Keating M.
    Am J Med; 1993 Jan 13; 94(1):69-74. PubMed ID: 8420302
    [Abstract] [Full Text] [Related]

  • 20. [A case of chronic myelocytic leukemia with B-lymphoid crisis responding to the VP therapy followed by lymphoid-myeloid crisis].
    Tomiyama J, Kamiyama T, Momoi M, Kudou H, Adachi Y, Kinugasa K, Takase K, Ookawa Y.
    Rinsho Ketsueki; 1987 Mar 13; 28(3):434-40. PubMed ID: 3475488
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.